Prevention of metabolic disorders and cellular dysfunction in adults. Encounter for screening for other specified diseases and disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Aged between 20 and 45 years BMI ranging from 22 to 30 no history of chronic metabolic, cardiovascular, or nutritional diseases no engagement in regular intense exercise in the past six months and no use of medications affecting metabolism
Exclusion criteria
Exclusion criteria: Presence of chronic or metabolic diseases History of intense exercise Use of specific supplements or medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In this study, the primary outcome variables include body composition (fat mass, lean mass, and bone mineral density), oxidative stress markers (such as MDA and total antioxidant capacity), gene and protein expression of key metabolic signaling pathways (including AMPK and mTOR), and cellular autophagy levels (measured via LC3 and Beclin-1 expression). These variables are selected to comprehensively assess the physiological and cellular effects of the exercise and dietary interventions. Timepoint: Outcome variables will be measured at three time points: before the intervention, at the end of week 12, and at the end of week 24. Method of measurement: Body composition will be assessed using DEXA (Dual-Energy X-ray Absorptiometry) scanning. Oxidative stress markers will be analyzed from blood samples using standard biochemical methods. Gene expression related to signaling pathways and autophagy will be measured through RNA extraction from peripheral cells, followed by RT-PCR and Western blot techniques. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hakim Sabzevari University